ENVALITH

NIRECO CORPORATION 1Q Earnings Preview

Focus on materialization of Optics capacity expansion investment and revenue conversion of JPY 6.637B order backlog; full-year contribution from Oyo Koken Kogyo also to be confirmed

PublishedAugust 5, 2026 at 15:30 GMT+9

Summary

Nireco achieved double-digit YoY order growth across all business segments in FY2026/3, with order backlog reaching JPY 6.637B (+28.5%). The key variable for FY2027/3 1Q is the extent to which this robust backlog converts into recognized revenue. The company has indicated it will commence approximately JPY 2B in capacity expansion investment for the Optics business within one year, with the timing of investment decisions and financing progress drawing attention. With Oyo Koken Kogyo contributing for its first full fiscal year, the trajectory of earnings improvement in the Inspection Equipment business and profitability recovery through global expansion of the Control Equipment business will be critical to gauging achievability of the full-year guidance (revenue JPY 12.5B, operating income JPY 1.9B). The enhanced shareholder return policy (payout ratio ≥50%, DOE ≥3.0%) and a special dividend of JPY 1 per share from cross-shareholding disposals also serve as useful indicators for assessing management's stance on capital policy.

Key Points for Next Quarter

Key Points & FocusImplications

Backlog-to-Revenue Conversion1Q revenue progress rate against full-year guidance of JPY 12.5B

Prior-year 1Q revenue was approximately JPY 2.5B by our estimate. Against the JPY 6.637B backlog, a ~+15% YoY landing would be consistent with full-year plan achievement

Optics Capacity Expansion InvestmentTiming of capex decision and specifics on investment amount

~JPY 2B capex plan targeted for groundbreaking within this fiscal year. Progress to be confirmed in 1Q

Full Contribution from Oyo Koken KogyoRevenue/profit contribution across both Inspection Equipment and Optics segments

Prior year included only 4Q (~3 months) contribution. Full consolidation from 1Q should add approximately JPY 300–400M in revenue by our estimate

Inspection Equipment ProfitabilityWhether the segment swings to profitability

Segment loss of JPY -30M in FY2026/3. Revenue addition from Oyo Koken Kogyo's radiation measurement instruments and lapping of upfront investments bring breakeven within reach

OPM RecoveryConsolidated OPM trend YoY

FY2026/3 15.4% → FY2027/3 full-year guidance 15.2%. Focus is on whether COGS ratio improvement (FY2026/3: 59.8%) offsets rising SG&A (+JPY 133M)

Shareholder Returns & Capital EfficiencyCross-shareholding disposal progress and ROE improvement trajectory

FY2026/3 ROE 8.6% (FY2025/3: 9.7%). Key question is whether the upgraded payout ratio ≥50% / DOE ≥3.0% targets and cross-shareholding disposals contribute to ROE recovery

Global ExpansionOrder trends for CPC sales to India and collaboration with IMS

European revenue grew to JPY 309M (+43.8% YoY) in FY2026/3. Accumulation of Control Equipment orders in India and East Asia will be pivotal to medium-term growth

Key Issues from Previous Results (FY2026/3 4Q Results)

FY2026/3 delivered revenue of JPY 11.022B (+2.5%), securing top-line growth, but operating income declined to JPY 1.701B (-10.8%) due to inflation-driven cost increases. On the other hand, double-digit order growth across all segments, driving backlog to JPY 6.637B (+28.5%), is a positive read-through as growth fuel for FY2027/3 and beyond. With the formulation of "NIRECO-VISION 100" looking ahead to the company's 100th anniversary in 2031, and strengthened shareholder return policies, Nireco has entered a new phase on both the growth and capital policy fronts.

1. Optics Backlog Conversion and Capacity Expansion Progress

  • Prior Year:
    Revenue JPY 2.854B (-1.6%), segment profit JPY 1.024B (-4.1%), order backlog JPY 2.601B (+47.0%)
  • This Year's Checkpoints:
    Decision-making/groundbreaking status of ~JPY 2B capacity expansion capex; sustainability of deep ultraviolet-related orders
  • Key Metrics:
    Whether 1Q-end backlog is maintained or increases vs. prior year-end; confirmation of capex progress
The Optics business posted FY2026/3 revenue of JPY 2.854B (-1.6%), declining modestly, but secured a batch of optical component orders and multiple new laser equipment orders in 4Q, driving backlog to JPY 2.601B (+47.0%).

2. Full Consolidation of Oyo Koken Kogyo and Inspection Equipment Profitability

  • Prior Year:
    Inspection Equipment revenue JPY 1.904B (+20.3%), but segment loss of JPY -30M (improved from JPY -89M in prior year)
  • This Year's Checkpoints:
    Whether full contribution from Oyo Koken Kogyo enables the Inspection Equipment business to turn profitable
  • Key Metrics:
    Positive/negative segment profit for Inspection Equipment; improvement in returns on segment assets of JPY 3.311B
Oyo Koken Kogyo was acquired as a subsidiary in October 2025 and contributed only in 4Q (~3 months) of FY2026/3. Its contribution spanning two segments—radiation measurement instruments (Inspection Equipment) and crystal optics (Optics)—will fully materialize on a full-year basis.

3. Control Equipment Recovery and Global Expansion

  • Prior Year:
    Steel & non-ferrous metals revenue JPY 3.209B (+6.3%); functional films & flexible packaging revenue JPY 2.549B (-8.6%)
  • This Year's Checkpoints:
    Initial orders from Indian market development through IMS collaboration; sustainability of order recovery in the film & flexible packaging segment
  • Key Metrics:
    Segment margin recovery trajectory (FY2026/3: 24.3% vs. FY2025/3: 26.8%); expansion of overseas revenue mix
The Control Equipment business posted FY2026/3 revenue of JPY 5.758B (-0.8%) and segment profit of JPY 1.398B (-10.1%), declining on both top and bottom lines, though order backlog grew to JPY 3.214B (+18.8%). The steel and non-ferrous metals segment remained solid, while the functional films and flexible packaging segment continued to face headwinds from the secondary battery industry slowdown.

4. Enhanced Shareholder Return Policy and Capital Efficiency

  • Prior Year:
    ROE 8.6% (FY2025/3: 9.7%), payout ratio 45.2%, DOE 3.9%, equity ratio 82.6%
  • This Year's Checkpoints:
    Progress on cross-shareholding disposals; continuation of share buybacks
  • Key Metrics:
    Achievability of FY2027/3 forecast dividend of JPY 35 (payout ratio 51.8%); ROE improvement trajectory (estimated ~8.4% by our calculation based on net income guidance of JPY 1.45B)
The dividend policy was upgraded to "consolidated payout ratio ≥50% and DOE ≥3.0%" (previously: payout ratio ≥45%, DOE ≥2.5%), with a JPY 3 per share special dividend from cross-shareholding disposals. Share buybacks of JPY 513M and cancellation of JPY 499M in treasury shares were also executed.

5. Cost Structure and Margin Recovery

  • Prior Year:
    Gross profit margin 40.2% (FY2025/3: 41.8%), OPM 15.4% (FY2025/3: 17.7%)
  • This Year's Checkpoints:
    Degree of continued inflationary impact; absorption of fixed cost increases from Oyo Koken Kogyo consolidation
  • Key Metrics:
    1Q OPM trend YoY; directional indication relative to full-year OPM guidance of 15.2%
FY2026/3 saw COGS ratio deteriorate by +1.6pt to 59.8% (FY2025/3: 58.2%), with SG&A also rising to JPY 2.725B (+5.1%). OPM declined to 15.4% (FY2025/3: 17.7%).

Timely Disclosure & Industry Trends

  • 2026/06/12
    Notice Regarding Stock Split, Partial Amendment to Articles of Incorporation Due to Stock Split, and Revision of Dividend Forecast Notice Regarding Stock Split, Partial Amendment to Articles of Incorporation Due to Stock Split, and Revision of Dividend Forecast
  • 2026/05/15
    Release of Growth Project "NIRECO-VISION 100" - A five-year growth vision formulated looking ahead to the company's 100th anniversary in 2031. Centered on measurement, inspection, and control technologies, the plan targets expanded collaboration with domestic and overseas partners, making it an important medium-term investment theme. Release of Growth Project "NIRECO-VISION 100"
  • 2026/05/14
    Optics Business ~JPY 2B Capacity Expansion Investment Plan Announced - Targeting operational launch by FY2029/3 to meet rising demand for optical components used in semiconductor inspection equipment. This represents the company's largest-ever growth investment, with groundbreaking progress during this fiscal year a key watch item. FY2026/3 Earnings Presentation Materials

Previous Quarter Results (FY2026/3 4Q Actual)

Nireco operates across three business segments—Control Equipment, Inspection Equipment, and Optics—and is a niche-top company providing measurement, inspection, and control systems essential to production lines in steel, semiconductors, food, and other manufacturing industries. FY2026/3 saw earnings decline due to inflation-driven cost increases, but all segments achieved double-digit order growth, with backlog reaching a record-high JPY 6.637B. The acquisition of Oyo Koken Kogyo (October 2025) broadened the business portfolio, and the company formulated "NIRECO-VISION 100," a growth vision targeting its 100th anniversary in 2031. The shareholder return policy was also upgraded to payout ratio ≥50% / DOE ≥3.0%, marking a phase where the company aims to balance growth investment with capital efficiency.

ItemAmountYoYvs. GuidanceNotes
RevenueJPY 11.022B+2.5%-4Q consolidation contribution from Oyo Koken Kogyo; Optics revenue -1.6% as laser equipment cycle wound down
Operating IncomeJPY 1.701B-10.8%-COGS ratio +1.6pt deterioration (59.8%); SG&A +5.1% increase
Recurring ProfitJPY 1.794B-11.5%-Decline in non-operating income (dividend income -JPY 18M, etc.)
Net IncomeJPY 1.441B-7.7%-Supported by extraordinary gains of JPY 197M (securities sale gain JPY 91M, negative goodwill JPY 64M, etc.)
EPSJPY 196.75-6.8%-Period-average shares outstanding: 7,327K shares (reflecting share buyback/cancellation impact)

Guidance Achievement Rate vs. Full-Year Plan: N/A as this represents full-year results. FY2027/3 full-year guidance calls for revenue JPY 12.5B (+13.4%), operating income JPY 1.9B (+11.7%); 1H cumulative plan: revenue JPY 5.8B, operating income JPY 730M.

Company Information

  • Company Name
    : NIRECO CORPORATION
  • Ticker Code
    : 6863
  • Listed Exchange
    : Tokyo Stock Exchange Standard Market
  • Fiscal Year-End
    : March
  • Core Businesses
    : Development, manufacturing, and sales of Control Equipment (web guiding systems, measurement devices, etc.), Inspection Equipment (surface inspection systems, food inspection systems, radiation measurement instruments, etc.), and Optics (optical components for semiconductor inspection equipment, laser systems, etc.)
Disclaimer

ENVALITH, INC. ("ENVALITH") provides exclusive research coverage services to domestic and international institutional investors, as well as domestic individual investors, with the objective of contributing to the development of global and Japanese capital markets by providing information necessary for considering investments in Japanese listed companies.

  • Purpose and Disclaimer Regarding Investment Decisions

    This report has been prepared solely for informational purposes and does not constitute a solicitation to acquire, sell, or hold securities or any other financial products. Furthermore, this report does not constitute specific investment, financial, or tax advice. Any opinions, judgments, or recommendations contained herein are not intended to induce investment activities. Please be advised that all investment decisions must be made based on the investor's own responsibility and judgment, and ENVALITH and subject company shall not be involved in any such investment decisions.

  • Information Sources, Accuracy, and Disclaimer of Warranty

    This report has been prepared based on a formal request from the subject company, utilizing information provided by and interviews conducted with said company. By using this report, you are deemed to have agreed to the following: 1. Information Sources: This report is prepared on the assumption that the publicly available information and information disclosed by the subject company and provided during interviews is true and reliable. ENVALITH has not independently verified or validated the veracity of such information. 2. Accuracy: The interpretations, analyses, and hypotheses or conclusions based thereon contained in this report are independently derived by ENVALITH using its own perspectives and analytical methods based on the information mentioned in the preceding paragraph. 3. Disclaimer of Warranty: In the event that there are errors or omissions in the information disclosed by the subject company, ENVALITH and subject company shall not be held liable for any inaccuracies in this report resulting therefrom. ENVALITH and subject company make no warranties, whether express or implied, regarding the accuracy, safety, validity, completeness, or any other aspect of this report, nor regarding the past or future performance of the subject company.

  • Limitation of Liability

    ENVALITH and subject company shall not be liable for any costs, damages, or losses (including direct, indirect, incidental, consequential, or punitive damages) arising from the use of this report or the information obtained therefrom. Users of this report acknowledge and agree that such use is at their own risk.

  • Potential Conflicts of Interest

    ENVALITH may have, or may have in the future, business relationships with the subject company. Accordingly, investors should be aware that conflicts of interest may exist that could affect the objectivity of this report.

  • No Obligation to Change or Update Content

    The contents and opinions in this report, as well as the information upon which it is based, are current as of the date of preparation and are subject to change without notice. Please be advised that ENVALITH is under no obligation to update the contents of this report, and investors must verify the timeliness of the information on their own.

  • Governing Language

    This report is prepared in Japanese, English, and Chinese. In the event of any discrepancy or difference in interpretation between the language versions, the Japanese version shall be treated as the original and shall prevail.

  • Copyright

    All rights (including copyrights) relating to this report belong to ENVALITH. Any reproduction, redistribution, or other use of all or part of this report without the prior written permission of ENVALITH is strictly prohibited.

  • Use for Other Investment Products

    Except where ENVALITH has provided prior written approval, the use of this report and the trademarks or trade names of ENVALITH or the subject company in connection with the information distribution, transaction, sales promotion, or advertising of any investment products (including derivatives, structured products, investment trusts, or investment assets whose price, return, or performance is based on or linked to this report) is strictly prohibited.